THE NUCLEAR FACTOR κB (NFκB) AND NOTCH SIGNALLING PATHWAYS AND BRCA1 MRNA EXPRESSION IN STAGE IV NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (P)

被引：0
|
作者：
Santarpia, Mariacarmela [1 ]
Sanchez-Ronco, Maria [2 ]
Magri, Ignacio
Angel Molina, Miguel
Viteri, Santiago
Costa, Carlota
Gasco, Amaya
Gonzalez-Cao, Maria
Mederos, Nuria
Salazar, Fernanda
Bertran-Alamillo, Jordi
Jimenez-Capitan, Ana
Altavilla, Giuseppe [1 ]
Benlloch, Susana
Yeste, Zaira
Aldeguer, Erika
Taron, Miquel [3 ]
Rosell, Rafael [3 ]
机构：
[1] Univ Hosp Policlin G Martino, Milan, Italy
[2] Univ Alcala de Henares, Alcala De Henares 99775, Spain
[3] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Badalona, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NFkB; Notch pathways; Non-Small-Cell Lung Cancer; BRCA1 mRNA expression;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S993 / S994
页数：2
相关论文
共 50 条
  • [31] The Prognostic Impact of BRCA1 Protein Expression in Patients With Non-small Cell Lung Cancer
    Gachechiladze, M.
    Skarda, J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S184 - S184
  • [32] Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer
    Hurkmans, Daan P.
    Basak, Edwin A.
    Schepers, Nina
    Oomen-De Hoop, Esther
    Van der Leest, Cor H.
    El Bouazzaoui, Samira
    Bins, Sander
    Koolen, Stijn L. W.
    Sleijfer, Stefan
    Van der Veldt, Astrid A. M.
    Debets, Reno
    Van Schaik, Ron H. N.
    Aerts, Joachim G. J., V
    Mathijssen, Ron H. J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [33] The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy
    Zheng, B.
    Zheng, W.
    Zhu, Y.
    Guo, C.
    Wu, W.
    Chen, C.
    ANNALS OF ONCOLOGY, 2013, 24 (04) : 1130 - 1130
  • [34] Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer
    Laura Bonanno
    Carlota Costa
    Margarita Majem
    Jose-Javier Sanchez
    Ignacio Rodriguez
    Ana Gimenez-Capitan
    Miquel Angel Molina-Vila
    Alain Vergnenegre
    Bartomeu Massuti
    Adolfo Favaretto
    Massimo Rugge
    Cinta Pallares
    Miquel Taron
    Rafael Rosell
    BMC Cancer, 16
  • [35] Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer
    Bonanno, Laura
    Costa, Carlota
    Majem, Margarita
    Sanchez, Jose-Javier
    Rodriguez, Ignacio
    Gimenez-Capitan, Ana
    Angel Molina-Vila, Miquel
    Vergnenegre, Alain
    Massuti, Bartomeu
    Favaretto, Adolfo
    Rugge, Massimo
    Pallares, Cinta
    Taron, Miquel
    Rosell, Rafael
    BMC CANCER, 2016, 16
  • [36] The role of BRCA1 and AEG1 mRNA expression in advanced non-small-cell lung cancer (NSCLC) patients (p) with EGFR activating and pretreatment T790M mutations receiving the combination of erlotinib plus bevacizumab (E plus B) in the BELIEF trial
    Rosell, Rafael
    Karachaliou, Niki
    Gimenez-Capitan, Ana
    Codony-Servat, Caries
    Gautschi, Oliver
    Felip, Enriqueta
    Curioni-Fontecedro, Alessandra
    Peters, Solange
    Ponce-Aix, Santiago
    Fruh, Martin
    Pless, Miklos
    Popat, Sanjay
    Cuffe, Sinead
    Bidoli, Paolo
    Favaretto, Adolfo
    Kamnnler, Roswitha
    Dafni, Urania
    Tsourti, Zoi
    Molina-Vila, Miguel Angel
    Stahel, Rolf A.
    CANCER RESEARCH, 2016, 76
  • [37] Results of a Surgical Resection for Patients With Stage IV Non-Small-Cell Lung Cancer
    Hanagiri, Takeshi
    Takenaka, Masaru
    Oka, Soich
    Shigematsu, Yoshiki
    Nagata, Yoshika
    Shimokawa, Hidehiko
    Uramoto, Hidetaka
    Tanaka, Fumihiro
    CLINICAL LUNG CANCER, 2012, 13 (03) : 220 - 224
  • [38] Stage IV Non-Small-Cell Lung Cancer in Older Patients: Survival analysis
    Yu, Chin-Hsiu
    Wu, Yu-Lung
    Chen, Ru-Yih
    Cheng, Ya-Ai
    Lin, Min-Hsi
    PSYCHO-ONCOLOGY, 2018, 27 : 112 - 113
  • [39] BRCA1 and Astrocyte Elevated Gene-1 (AEG-1) Expression and Outcome of Erlotinib-Treated Non-Small-Cell Lung Cancer (NSCLC) Patients (p) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations
    Taron, M.
    Benlloch, S. B.
    Sanchez, J. J. S.
    Rosell, R. R.
    Costa, C. C.
    Queralt, C. Q.
    Mayo, C. M.
    de Aguirre, I. A.
    Moran, T. M.
    Massuti, B. M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S593 - S593
  • [40] SECOND LINE CHEMOTHERAPY WITH PEMETREXED (P) FOR PATIENTS IN STAGE IIIB/IV NON SMALL CELL LUNG CANCER (NSCLC)
    Bensaou, Malika Gamaz
    Mehenni, Nawel
    Bouzid, Kamel
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1160 - S1160
12345